BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gao W, Li Y, Zhang T, Lu J, Pan J, Qi Q, Dong S, Chen X, Su Z, Li J. Systematic Analysis of Chemokines Reveals CCL18 is a Prognostic Biomarker in Glioblastoma. J Inflamm Res 2022;15:2731-43. [PMID: 35509325 DOI: 10.2147/JIR.S357787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Caverzán MD, Beaugé L, Oliveda PM, Cesca González B, Bühler EM, Ibarra LE. Exploring Monocytes-Macrophages in Immune Microenvironment of Glioblastoma for the Design of Novel Therapeutic Strategies. Brain Sciences 2023;13:542. [DOI: 10.3390/brainsci13040542] [Reference Citation Analysis]
2 Ye Y, Zhong W, Qian J, Zhang J, Xu T, Han R, Han J, Wang C, Song L, Zeng X, Wang H. Comprehensive analysis of the prognosis and immune infiltrates for the BET protein family reveals the significance of BRD4 in glioblastoma multiforme. Front Cell Dev Biol 2023;11:1042490. [PMID: 36711038 DOI: 10.3389/fcell.2023.1042490] [Reference Citation Analysis]
3 Yu J, Ma H, He J, Wang M, Yu B, Ge S, Dai Z. A pan-cancer analysis of the oncogenic role of ATP binding cassette subfamily E member 1 (ABCE1) in human tumors: An observational study. Medicine (Baltimore) 2022;101:e31849. [PMID: 36401432 DOI: 10.1097/MD.0000000000031849] [Reference Citation Analysis]